Response to Comments: MolDX: Molecular Testing for Risk Stratification of Thyroid Nodules

This document A59735 is a response-to-comments notice regarding MolDX Local Coverage Determination L39646 for molecular testing to risk-stratify thyroid nodules and does not itself specify coverage criteria. It records the comments period (8/31/2023–10/14/2023) and the LCD notice/effective dates (notice begins 8/29/2024; effective 10/13/2024); consult the final L39646 for the actual indications, limitations, documentation, and frequency rules.

"This document is a response-to-comments notice for MolDX LCD L39646; consult the final MolDX LCD L39646 (effective 2024-10-13) for the definitive coverage criteria for molecular testing for risk st..."

Sign up to see full coverage criteria, indications, and limitations.